This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US states object to special master report over Sandoz price-fixing settlement

( July 21, 2025, 21:13 GMT | Official Statement) -- MLex Summary: A group of 43 US states and territories filed objections to a federal judge over special master Lawrence Stengel's report recommending the court deny their motion to intervene in a price-fixing settlement between Sandoz and end-payer plaintiffs. The report, which recommends denying the states' motion, "adopts an unprecedented and unsupported view of nonparty standing to intervene," the states said, and "discards binding precedent... that protects nonparties from the legal prejudice that results when their claims are terminated by a settlement without due process," they said in their objections filed to the US Eastern District of Pennsylvania. The states' damages claims are sovereign, and their being settled out by private parties is legal prejudice and injury to the states under Article III, the filing said.See attached document: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections